Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  BioLineRX Ltd.       IL0011015182

BIOLINERX LTD.

 SummaryChartsNewsCalendarCompany 
Company
BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates under development consist of BL-1020 that is in Phase II/III clinical trials to... 
More about the company
Latest news on BIOLINERX LTD.
06/13BIOLINERX : to Present at the JMP Securities 2019 Life Sciences Conference
PR
05/14BIOLINERX REPORTS FIRST QUARTER 2019 : 00 am EDT
AQ
05/14BIOLINERX : Reports First Quarter 2019 Financial Results and Provides Corporate ..
PR
05/07BIOLINERX TO REPORT FIRST QUARTER 20 : 00 a.m. EDT
AQ
05/07BIOLINERX : to Report First Quarter 2019 Results on May 14, 2019
PR
05/07BIOLINERX : Announces FDA Approval of IND Application for AGI-134, a Novel Immun..
PR
03/28BIOLINERX : Reports Year End 2018 Financial Results and Provides Corporate Updat..
PR
03/27BIOLINERX : Announces Successful Engraftment Data From Phase 3 GENESIS Trial for..
PU
03/22BIOLINERX TO REPORT ANNUAL 2018 RESU : 00 a.m. EDT
AQ
03/21BIOLINERX : to Report Annual 2018 Results on March 28, 2019
PR
More news
Analyst Recommendations on BIOLINERX LTD.
More recommendations
Sector news : Biotechnology & Medical Research - NEC
06/21Regeneron, Sanofi Report Positive Topline Phase 2 Asthma Results
DJ
06/20EXELIXIS : Phase 3 Combination Study for Melanoma Didn't Meet Primary Endpoint
DJ
06/19PFIZER : Fitch Puts Pfizer on Watch Negative, Notes Leverage Increase
DJ
06/19GILEAD SCIENCES : Sets Collaboration With Nurix Therapeutics
DJ
06/18WHAT'S NEWS : Business & Finance -- WSJ
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart BIOLINERX LTD.
Duration : Period :
BioLineRX Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Philip Adam Serlin Chief Executive Officer & Head-Investor Relations
Aharon Schwartz Chairman
Mali Zeevi Chief Financial Officer
Abi Vainstein-Haras Vice President-Clinical Development
Sorani Ella Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
BIOLINERX LTD.2.57%53
IQVIA HOLDINGS INC35.52%26 223
LONZA GROUP28.39%24 012
CELLTRION, INC.--.--%20 953
INCYTE CORPORATION36.69%17 061
EXACT SCIENCES CORPORATION80.30%13 037